The UK Renal Registry (UKRR) was established by
the Renal Association to act as a resource in the development of patient care in renal disease. 1.2 The Registry acts as a source of comparative data for audit, benchmarking, planning, policy and research. The collection and analysis of sequential biochemical and haematological data is a unique feature of the Registry. 1.3 Agreements have been made with participating renal centres, which ensure a formal relationship with the Registry and safeguard confidentiality. 1.4 The essence of the agreement is the acceptance of the Renal Registry Data Set Specification (RRDSS) as the basis of data transfer and retention. 1.5 Data is collected quarterly to maintain centre-level quality assurance, with the results being published in an annual report. 5 Together with the need to know the demographic and structural elements, the NHS has developed a need to underpin clinical activity more rigorously through the scientific evidence base (for example, the Cochrane Initiative) and by quality assurance activity through audit. These initiatives require comprehensive information about the structures, processes and outcomes of RRT, which go well beyond the detail previously compiled by the ERA-EDTA. 2.6 The Registry is recognised as one of the very few high-quality clinical databases available for general use [6] . The collection of data by download of electronic records from routine clinical databases is uncommon, has been highly successful and is being imitated worldwide. 2.7 The Renal Association has made a start in the area of audit by publishing guidelines in 'Renal Standards' documents. It was apparent during the development of the Standards that many of the desirable criteria of clinical performance were uncertain or unknown and that only the accumulated data of practicing renal centres could provide the evidence for advice on best practice and what might be achievable. A common data registration provides the simplest device for such an exercise.
2.8 The continuing emphasis on evidence-based practice is being supported by changes in research funding (Culyer Report and recent national statements), which lean towards collaborative projects and include both basic science and 'health services research' components. It is apparent that an RRT database is invaluable to a wide range of research studies. 2.9 It can be seen that the need for a Registry of RRT has developed for a variety of reasons: international comparisons, national planning, local Trust, PCT and health authority management, standard setting, audit and research. The opportunity for data gathering arises partly from improvements in information technology. Although it was possible to see the need for a national renal database 20 years ago, the circumstances have become ideal for the maintenance of a data repository, supported by the clinical users and resourced for national benchmarking as a routine part of RRT management. 2.10 The provisional expectations of earlier annual reports can now be replaced by confident assertions, built on the experience of nine years of publication, about the role and potential of the UKRR. The integration of the various elements of Renal Association strategy is being pursued through the Clinical Affairs Board (CAB).
A:3 Statement of intent
The Renal Registry provides a focus for the collection and analysis of standardised data relating to the incidence, clinical management and outcome of renal disease. Data will be accepted quarterly according to the RRDSS by automatic downloading from renal centre databases. There will be a core dataset, with optional elements of special interest that may be entered by agreement for defined periods. A report will be published annually to allow a comparative audit of facilities, patient demographics, quality of care and outcome measures. Participation is mandated through the recommendation in the Renal National Service Framework. There will be an early concentration on RRT, including transplantation, with an extension to other nephrological activity over time. The Registry will provide an independent source of data and analysis on national activity in renal disease. data to the EDTA-ERA Registry will be through the Renal Registry. The Scottish Renal Registry already sends data directly to the EDTA-ERA Registry. 4.5 A paediatric database has been developed in collaboration with the UKRR, and the two databases are compatible. These two databases are in the process of being integrated, which will allow long-term studies of renal cohorts over a wide age range. 4.6 Close collaboration has been achieved with the NHS Blood and Transplant organisation -(formerly UK Transplant) giving joint benefits. Data aggregation and integration has led to joint presentations and publications. The description of the entire patient journey in RRT by this means is a source of continuing insight and usefulness. 4.7 The basis of participation for renal centres nationally is an agreement to accept the RRDSS for the transmission and retention of data. This is currently increasing to a core dataset of approximately 400 items and further optional elements, which will be returned on a special understanding with the renal centres for a defined period of reporting.
4.8 The UKRR is part of the team undertaking an investigation into the necessary scope of national audit for the Healthcare Quality Improvement Partnership, in the light of the NSF. 4.9 The retention of patient identifiable information, necessary in particular for the adequate tracing of patients, has been approved by the Patient Information Advisory Group (PIAG), under Section 60 of the Health and Social Care Act. This is pending the introduction of mechanisms that will preserve patient anonymity through encryption of a unique patient identifier. 4.10 It is anticipated that the UKRR will receive data from the Secondary Uses Service (SUS) of the national IT programme, Connecting for Health, when it is fully instituted. The detail of data routing from renal centre clinical systems to the national database has yet to be established.
A:5 The role of the UK Renal Registry for patients
5.1
The goal of the UKRR is to improve care for patients with renal disease. The appropriate use of UKRR information should improve equity of access to care, adequacy of facilities, availability of important but high-cost therapies such as erythrocyte stimulating agents and the efficient use of resources. The continuing comparative audit of the quality of care should facilitate the improvement of care and outcomes of care. It is intended to identify and publish examples of good practice. In such ways, patients will be the ultimate beneficiaries of the exercise. 5.2 A leaflet has been provided, in collaboration with the NKF, by which patients may opt out of the collection of identifiable data by the UKRR if they wish. 5.3 Information from the UKRR will complement the individual records available on 'RenalPatientView' where it is accessible. activities, particularly in relation to national standards and in comparison with other renal centres. 6.2 The UKRR is run by a committee of the Renal Association and therefore by colleagues with similar concerns and experience. 6.3 The Renal Standards documents are designed to give a basis for centre structure and performance, as well as patient-based elements such as case mix and outcomes. It is anticipated that Standards will become increasingly based on research evidence and the Cochrane Collaboration has recently resourced reviews of renal topics, which will support this conversion. 6.4 The UKRR data are available to allow the comparative review of many elements of renal centre practice. Centre data are presented to allow a contrast of individual centre activity and results against national aggregated data. Sophisticated analyses of patient survival for example, are a unique resource to exclude any anomalies of performance and standardise for centre caseload, etc. 6.5 Reports of demographic and treatment variables are available to the participating centres for distribution to Trusts, PCTs, Strategic Health Authorities and Commissioners, as well as Renal networks, as required and agreed with the centre. Reports should facilitate discussion between clinicians, Trust officers and commissioners. 6.6 Customised data reports can be made available by agreement with the Registry Committee. A charge to cover any costs incurred may be requested. 6.7 The UKRR is developing the publication of focused and extended synopses of chapters from the annual Report. These 'dips' will facilitate the appreciation and application of comparative data and will allow wider distribution. 6.8 The Registry Committee welcome suggestions for topics of national audit or research that colleagues feel are of sufficiently widespread interest for the UKRR to undertake. 6.9 The database has been designed to provide research facilities for future participation in national and international trials. Members of the Renal Association and other interested parties are welcome to apply to the Registry Committee to conduct local or national audit and research using the database. All such projects will need the agreement of the Registry Committee and any costs involved will need to be met by the applicants.
6.10 These facilities will be sustainable only through cooperation between nephrologists and the UKRR. There is a need for high-quality and comprehensive data entry at source. A:7 The role of the UK Renal Registry for Trust managers 7.1 As the basis of the clinical governance initiative, the gathering and presentation of clinical data are regarded as essential parts of routine patient management in the health service. 7.2 One of the principles of health service informatics is that the best data are acquired from clinical information recorded at the point of health care delivery. 7.3 Renal services data entered on local systems by staff directly engaged with patients are likely to be of the highest quality and it is these that the UKRR intends to capture. 7.4 The UKRR provides a cost-effective source of detailed information on renal services. 7.5 The regular reports of the UKRR supply details of patient demographics, treatment numbers, treatment quality and outcomes. Data are compared with both national standards and national performance, for benchmarking and quality assurance. The assessment of contract activity and service delivery is possible through these data returns,
